ArticleCureus2026
Chronic Granulomatous Interstitial Nephritis Presenting Five Years After Intravesical Bacillus Calmette-Guérin Therapy: A Case Report and Literature Review.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intravesical administration of Bacillus Calmette-Guérin (BCG) has been the standard treatment for non-muscle invasive bladder cancer (NMIBC). Its efficacy in preventing recurrence and tumor progression has been well established; however, rare immune-mediated complications, particularly parenchymal renal involvement, pose significant diagnostic challenges. This report describes an exceptional case: that of a 73-year-old man who developed renal failure five years after his last BCG instillation. Histopathological examination revealed granulomatous interstitial nephritis. This case is remarkable for its exceptionally long and unusual latency period, which generally manifests within days to months in other patients. After initiating corticosteroid therapy, the patient experienced partial renal recovery and stabilization of renal function during follow-up, highlighting the potential role of immunological mechanisms in delayed renal injury. This study underscores the need for long-term renal monitoring in patients treated with BCG immunotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.